SCHOTT Pharma

SCHOTT Pharma is a global leader in designing science-grounded solutions for medication safety and ease of use, driven by a commitment to human health. Operating within the Manufacturing, Glass & Clay, and Chemicals sectors, the company focuses on delivering high-quality injectable drug containment and delivery systems. Its diverse portfolio includes prefillable glass and polymer syringes, cartridges, vials, and ampoules, catering to critical pharmaceutical needs worldwide. SCHOTT Pharma emphasizes innovation through in-house patent development and a state-of-the-art Research and Development Center in Switzerland, attracting specialized R&D professionals.

The company maintains a significant operational footprint with manufacturing sites strategically located across major pharmaceutical hubs in Europe, the Americas, and Asia, supporting its global reach. Employing between 1,000 - 5,000 individuals, SCHOTT Pharma fosters a culture of scientific advancement and operational excellence. For insights into the people driving these innovations, you can Meet SCHOTT Pharma's team. The company's dedication to advancing pharmaceutical delivery systems is evident in its continuous investment in cutting-edge technologies and talent.

With a reported revenue of $1.1B, SCHOTT Pharma demonstrates substantial market presence and financial stability. A notable event in its recent financial history includes a stock issuance of $989 million in September 2023, underscoring investor confidence and capacity for growth. The company's strategic focus on R&D and global manufacturing ensures it remains at the forefront of pharmaceutical containment solutions. Explore detailed financial performance and investment insights by visiting Explore financial highlights. SCHOTT Pharma's ticker symbol is FRA: 1SXP.